DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Chandarlapaty S, Chen D, He W. et al.
Prevalence of ESR1 mutations in cell-free DNA and outcomes in metastatic breast cancer: a secondary analysis of the BOLERO‑2 clinical trial.
JAMA Oncol 2016;
2: 1310-1315
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.